GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $6.1B | +2.7% | 3.3% | 6.8% |
| Research and development (TTM) | $6.1B |
|---|---|
| YoY | +2.7% |
| 5-year CAGR | 3.3% |
| 10-year CAGR | 6.8% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $5.8B | −1.8% |
| 2024 | $5.9B | +3.3% |
| 2023 | $5.7B | +14.9% |
| 2022 | $5.0B | +8.2% |
| 2021 | $4.6B | −6.6% |
| 2020 | $4.9B | −45.9% |
| 2019 | $9.1B | +81.5% |
| 2018 | $5.0B | +34.4% |
| 2017 | $3.7B | −26.8% |
| 2016 | $5.1B | +69.1% |
| 2015 | $3.0B | +5.6% |
| 2014 | $2.9B | +34.6% |
| 2013 | $2.1B | +20.5% |
| 2012 | $1.8B | +43.2% |
| 2011 | $1.2B | +14.6% |
| 2010 | $1.1B | +14.2% |
| 2009 | $940M | +30.2% |
| 2008 | $722M | +22.1% |
| 2007 | $591M | — |